Skip to main content
. 2023 Oct 26;55(2):2269586. doi: 10.1080/07853890.2023.2269586

Table 1.

Demographics, clinical characteristics, and echocardiographic imaging findings in SARS-CoV-2-positive athletes compared to matched negative controls.

  Combined
Female
Male
  COVID-19 Positive Negative Control p Value COVID-19 Positive Negative Control p Value COVID-19 Positive Negative Control p Value
N 61 61 24 24 37 37
Age, yrs 20 ± 1 20 ± 2 0.8 19 ± 1 19 ± 1 0.6 21 ± 1 21 ± 2 >0.9
Sex, % women 39 39
BMI, kg/m2 27 ± 5 25 ± 3 0.2 23 ± 4 24 ± 2 0.8 29 ± 5 27 ± 4 0.04
Days since diagnosis 40 ± 38 51 ± 43 31 ± 32
Vital signs                  
SBP, mmHg 122 ± 11 127 ± 12 0.2 120 ± 10 122 ± 10 0.5 124 ± 11 130 ± 12 0.1
DBP, mmHg 63 ± 8 63 ± 7 0.8 62 ± 7 62 ± 6 0.9 63 ± 9 64 ± 7 0.7
LVmass, g 204 ± 62 207 ± 62 0.82 168 ± 54 172 ± 51 0.8 228 ± 56 229 ± 59 0.9
LVSV 76 ± 19 73 ± 16 0.36 65 ± 14 66 ± 17 0.8 84 ± 18 78 ± 14 0.15
IVSDd, mm 1.0 ± 0.2 1.1 ± 0.2 0.07 1.0 ± 0.2 1.0 ± 0.2 0.7 1.1 ± 0.2 1.2 ± 0.2 0.04
PWDd, mm 1.0 ± 0.2 1.0 ± 0.2 0.6 1.0 ± 0.2 1.0 ± 0.2 0.8 1.1 ± 0.2 1.1 ± 0.2 0.4
RWT 0.42 ± 0.08 0.48 ± 0.08 0.2 0.43 ± 0.09 0.43 ± 0.07 >0.9 0.41 ± 0.08 0.45 ± 0.09 0.07
LVM, g 204 ± 92 206 ± 62 0.8 168 ± 54 172 ± 50 0.4 228 ± 55 227 ± 59 >0.9
LVMi, g/ m2 96 ± 22 101 ± 25 0.3 90 ± 22 95 ± 22 0.6 100 ± 22 106 ± 24 0.4
LVEDD, cm 5.0 ± 0.6 4.8 ± 0.4 0.1 4.6 ± 0.5 4.6 ± 0.4 >0.9 5.2 ± 0.5 5.0 ± 0.4 0.01
LVEDDi, cm/m2 2.4 ± 0.3 2.4 ± 0.3 0.2 2.6 ± 0.4 2.6 ± 0.3 0.4 2.3 ± 0.2 2.3 ± 0.2 0.3
LVEDV, ml 127 ± 33 118 ± 24 0.19 107 ± 19 103 ± 20 0.5 140 ± 33 127 ± 21 0.09
LVEDVi, ml/m2 60 ± 11 58 ± 9 0.5 59 ± 10 57 ± 9 0.6 62 ± 12 59 ± 8 0.6
LVEF, % 65 ± 6 72 ± 8 <0.0001 67 ± 6 72 ± 8 0.02 64 ± 6 72 ± 8 <0.001
LVEF <50%, % 0 0 >0.9 0 0 >0.9 0 0 >0.9
SV, ml 76 ± 19 73 ± 16 0.4 65 ± 13 66 ± 16 0.4 84 ± 18 78 ± 14 0.2
SV, ml/m2 36.4 ± 7 37 ± 7 0.9 36 ± 8 36 ± 9 >0.9 37 ± 7 37 ± 6 >0.9
E 0.86 ± 0.15 0.90 ± 0.15 0.13 0.88 ± 0.1 0.96 ± 0.15 0.2 0.84 ± 0.17 0.86 ± 0.13 0.4
A 0.45 ± 0.10 0.4 ± 0.09 0.08 0.4 ± 0.06 0.41 ± 0.10 0.4 0.47 ± 0.12 0.41 ± 0.08 0.07
E/A 2.00 ± 0.5 2.3 ± 0.52 0.006 2.2 ± 0.4 2.4 ± 0.6 0.2 1.89 ± 0.48 2.14 ± 0.47 0.008
Septal e’ 0.16 ± 0.16 0.14 ± 0.03 0.3 0.13 ± 0.02 0.14 ± 0.02 0.3 0.18 ± 0.2 0.14 ± 0.02 0.3
Septal s’ 0.09 ± 0.01 0.09 ± 0.02 0.8 0.08 ± 0.01 0.08 ± 0.01 0.8 0.09 ± 0.02 0.10 ± 0.03 0.6
E/e’ 6.6 ± 1.7 6.7 ± 1.6 0.6 6.6 ± 1.2 6.9 ± 1.8 0.7 6.7 ± 1.9 6.5 ± 1.5 0.6

BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; IVSDd: intraventricular septum diastolic dimension; PWDd: posterior wall diastolic dimension; RWT: relative wall thickness; LVmass: left-ventricular mass; LVEDD: left-ventricular end-diastolic diameter; LVEDV: left-ventricular end-diastolic volume; LVESV: left-ventricular end-systolic volume; LVEF: left-ventricular ejection fraction; SV: stroke volume.